首页 | 本学科首页   官方微博 | 高级检索  
     

新型国产杂交捕获HPV检测技术在ASC-US人群分流中的应用效果评价
引用本文:徐慧芳,刘茵,赵冬梅,罗艳林,陈佩佩,郭珍,贾漫漫,郑黎阳,张璐瑶,李梦洁,张韶凯. 新型国产杂交捕获HPV检测技术在ASC-US人群分流中的应用效果评价[J]. 实用肿瘤学杂志, 2022, 36(2): 133-136. DOI: 10.11904/j.issn.1002-3070.2022.02.006
作者姓名:徐慧芳  刘茵  赵冬梅  罗艳林  陈佩佩  郭珍  贾漫漫  郑黎阳  张璐瑶  李梦洁  张韶凯
作者单位:河南省癌症中心; 郑州大学附属肿瘤医院; 河南省肿瘤医院; 河南省肿瘤防控工程研究中心; 河南省肿瘤预防国际联合实验室(郑州 450008)
基金项目:河南省科技攻关计划项目(编号:192102310105);河南省高等学校重点科研项目计划(编号:20A330005)
摘    要:目的 探讨基于杂交捕获原理的DH2检测技术在未明确意义的不典型鳞状细胞(Atypical squamous cells of undetermined significance,ASC-US)人群中的分流应用效果.方法 本研究于2016年10月—2018年10月在河南省新密市招募21~64岁普通女性参加研究.所有女性在...

关 键 词:宫颈癌  未明确意义的不典型鳞状细胞  分流  筛查
收稿时间:2021-04-08

Performance evaluation of a new domestic hybrid capture HPV detection technology for the management of ASC-US population
XU Huifang,LIU Yin,ZHAO Dongmei,LUO Yanlin,CHEN Peipei,GUO Zhen,JIA Manman,ZHENG Liyang,ZHANG Luyao,LI Mengjie,ZHANG Shaokai. Performance evaluation of a new domestic hybrid capture HPV detection technology for the management of ASC-US population[J]. Journal of Practical Oncology, 2022, 36(2): 133-136. DOI: 10.11904/j.issn.1002-3070.2022.02.006
Authors:XU Huifang  LIU Yin  ZHAO Dongmei  LUO Yanlin  CHEN Peipei  GUO Zhen  JIA Manman  ZHENG Liyang  ZHANG Luyao  LI Mengjie  ZHANG Shaokai
Affiliation:Henan Cancer Center,Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Henan Engineering Research Center of Cancer Prevention and Control,Henan International Joint Laboratory of Cancer Prevention,Zhengzhou 450008,China
Abstract:Objective The of this study was to explore the performance of DH2 detection technology based on the principle of hybrid capture for the management of atypical squamous cells of undetermined significance(ASC-US)population.Methods This study recruited participants from 21 to 64 years old general women in Xinmi county,Henan province from October 2016 to October 2018.All women would be subjected to gynecological examination and cervical exfoliative cytology collection after signing informed consent form.All cytological samples were detected by DH2 for high-risk HPV testing.At the same time,all subjects underwent colposcopy and tissue biopsy if necessary.The results of colposcopy and pathological diagnosis would be used as the gold standard for performance evaluation of DH2.Results A total of 302 women were enrolled with a median age of 52 years in the study.The DH2 test results were positive in 49 women(16.2%),3(1%)women were diagnosed with cervical intraepithelial neoplasia grade 2(CIN2),and 14(4.6%)women were diagnosed with cervical intraepithelial neoplasia grade 3 or worse(CIN3+)lesions.When CIN2+ was used as the clinical endpoint,the sensitivity,specificity,positive predictive value,and negative predictive value of DH2 were 82.4%,87.7%,28.6% and 98.8% respectively;when CIN3+ was used as the clinical endpoint,the sensitivity,specificity,and positive and negative predictive values of DH2 were 85.7%,87.2%,24.5% and 99.2%,respectively.Conclusion DH2 has high sensitivity and specificity in detecting CIN2+ and CIN3+ lesions in ASC-US population.Therefore,DH2 is promising in the management of ASC-US population and could reduce the health hazards of cervical cancer by combining with cytological screening methods.
Keywords:Cervical cancer  Atypical squamous cells of undetermined significance  Triage  Screening  
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号